Generics 10

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Plerixafor manufacturers

10 products found

Filters

10 products found

plerixafor

Vials, injection 24mg/1.2ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
China
GMP approvals
EU GMP
Unavailable markets
United Kingdom , Spain , Lithuania , Latvia , Estonia , Sweden , Norway , Finland
Manufacturer #9300

Manufacturer usually replies in 3 days

plerixafor

Vials, injection 24 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Available for
Licensing with supply, Distribution only
Manufacturer #17708

Manufacturer usually replies in 4 days

plerixafor

Injection 24 mg/1.2 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #15176

Manufacturer usually replies in 4 days

plerixafor

Vials, injection 24 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #22283

Manufacturer usually replies in 4 days

plerixafor

Injection 24 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #20510

Manufacturer usually replies in 2 days

plerixafor

Vials, injection 20 mg / ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
PICS
Manufacturer #17881
Quality, price, innovative molecules as well as the established validity of the active ingredients selected by the doctors due to their effectiveness and reliability, are key factors that enable the company to place its products in the hands of more than 1.5 million patients every month. It is dedicated to the development of pharmaceuticals for psychiatry, cardiology, diabetes, dentistry, gynecology, and oncology, among others.

Manufacturer usually replies in 4 days

plerixafor

Solution for injection 24 mg/1.2 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Turkey
GMP approvals
EU GMP, PICS
Manufacturer #2760

Manufacturer usually replies in 5 days

plerixafor

Solution for injection 20 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Argentina
GMP approvals
Argentina, Brazil, Pakistan, Paraguay, Peru, Uruguay, WHO, PICS
Unavailable markets
Argentina , Brazil , Chile , Ecuador , Paraguay , Peru , Uruguay
Manufacturer #16112

Manufacturer usually replies in 6 days

plerixafor

Injection 20 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #19912

Manufacturer usually replies in 18 days

plerixafor

Tablets 24 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #30013

Manufacturer usually replies in nan days

Plerixafor Manufacturers

Plerixafor is an immunostimulant mainly used for mobilizing hematopoietic stem cells in cancer patients into the bloodstream. The stem cells are then extracted from the blood and transplanted back to the patient. This medical remedy was developed by AnorMED, which was subsequently bought by Genzyme. Warnings: Follow all Instructions on your medicine package and label. It is wise to tell your healthcare providers about all your medical allergies, illnesses, and all medicines you use. Before taking this medicine: You should not use Plerixaforif you are allergic to it Plerixafor may also is used for purposes that may not have been listed in this medication guide.

How to use Plerixafor?

Read the Plerixafor Guide and, if available, the Patient Information Leaflet that will be provided by your pharmacist before you start taking Plerixafor. If you have any questions related to Plerixafor, ask your pharmacist or doctor. This medical drug is used by patients with certain sorts of cancer (multiple myeloma-MM, non-Hodgkin's lymphoma-NHL) to prepare them for stem cell transplant. Stem cells, which are usually found in the bone marrow, turn into white blood cells, red blood cells, and platelets.

How much money does Plerixafor cost?

It is obtainable in generic and brand versions. It is not covered by most Medicare and insurance plans, but pharmacy coupons can help balance the price. The cost of Plerixafor is around $8652.68. Prices may vary on the pharmacy you visit.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Plerixafor offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for Plerixafor manufacturers and Plerixafor suppliers that you are looking for. These also enable you to check the dossier status of Plerixafor, and the GMP approvals of the different variants of Plerixafor. Also, each manufacturer or supplier product description contains essential information about Plerixafor including clinical data, stability zones, countries where Plerixafor is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Ivermectin offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that Ivermectin manufacturers have, we qualify their companies before they are onboarded on the platform. This allows us to screen Ivermectin manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.